sir
william
osler
md
communityacquir
pneumonia
cap
one
underappreci
medic
ill
usa
combin
pneumonia
influenza
ninth
lead
caus
death
overal
common
caus
infecti
death
usa
caus
estim
death
number
like
underestim
mani
death
caus
directli
cap
code
sepsi
pneumonia
common
sourc
attribut
underli
condit
cancer
alzheim
diseas
pneumonia
termin
event
exampl
proxim
caus
death
patient
dementia
pneumonia
lower
respiratori
tract
infect
remain
lead
caus
infecti
death
world
well
exceed
death
tuberculosi
human
immunodefici
viru
hiv
malaria
combin
cap
common
reason
hospit
admiss
adult
usa
common
caus
sever
complic
includ
septic
shock
acut
respiratori
distress
syndrom
ard
acut
renal
failur
even
survivor
hospit
admiss
cap
associ
increas
subsequ
mortal
acceler
cognit
declin
cap
also
costli
estim
annual
cost
cap
usa
billion
indirect
cost
also
substanti
cap
major
caus
work
day
day
school
lost
ill
mortal
rate
cap
chang
littl
last
decad
two
factor
like
contribut
recent
decreas
widespread
use
conjug
pneumococc
vaccin
children
communityacquir
pneumonia
cap
common
caus
admiss
adult
usa
diagnosi
communityacquir
pneumonia
rel
easi
previous
healthi
patient
may
challeng
underli
cardiopulmonari
diseas
elderli
highest
yield
diagnost
test
cap
etiolog
critic
ill
risk
factor
drugresist
pathogen
major
hospit
cap
patient
treat
either
respiratori
fluoroquinolon
cephalosporinmacrolid
combin
altern
antibiot
treatment
base
presenc
multipl
risk
factor
drugresist
pathogen
ie
healthcareassoci
pneumonia
specif
risk
eg
travel
zoonot
risk
uniqu
syndrom
eg
toxinmedi
communityacquir
mrsa
syndrom
decis
regard
initi
placement
intens
care
unit
icu
tenuou
cap
patient
base
number
minor
physiolog
factor
laboratori
abnorm
associ
risk
subsequ
deterior
number
death
pneumonia
decreas
world
link
child
vaccin
pneumococcu
largescal
use
antibiot
indiachina
may
requir
avoid
excess
antibiot
therapi
pattern
radiograph
infiltr
occasion
help
differenti
diagnosi
etiolog
cavitari
cap
figur
limit
differenti
diagnosi
tabl
although
vari
somewhat
geograph
locat
convers
even
though
viral
atyp
bacteri
pneumonia
commonli
caus
diffus
interstiti
infiltr
pattern
distinct
enough
guid
antibiot
therapi
radiograph
pattern
also
associ
prognosi
initi
presenc
bilater
infiltr
consist
associ
greater
mortal
need
icu
care
rapid
increas
radiograph
infiltr
whether
due
uncontrol
infect
develop
ard
initi
hour
also
associ
antibiot
failur
need
icu
care
convers
presenc
pleural
effus
associ
better
prognosi
pneumonia
result
prolifer
microbi
pathogen
commonli
bacteria
occasion
virus
fungi
parasit
infecti
agent
alveoli
host
respons
pathogen
latter
critic
import
sinc
recent
data
demonstr
presenc
normal
bacteri
microbiom
alveoli
infect
lower
respiratori
tract
occur
level
vari
proport
viral
bacteri
etiolog
level
confus
pneumonia
respiratori
bronchiol
due
respiratori
syncyti
viru
rsv
children
classic
exampl
confus
cap
proxim
level
infect
increas
secret
airway
narrow
due
rsv
airway
infect
lead
radiograph
infiltr
atelectasi
convers
infect
progress
entir
respiratori
tract
influenza
uri
follow
cough
wheez
tracheobronch
culmin
hypoxemia
infiltr
influenza
pneumonia
classic
pneumonia
thought
result
introduct
pathogen
lower
respiratori
tract
four
pathway
aspir
oropharynx
like
common
bacteri
pneumonia
smallvolum
aspir
occur
frequent
sleep
especi
elderli
patient
decreas
level
conscious
virus
tuberculosi
inhal
contamin
droplet
rare
pneumonia
occur
via
hematogen
spread
eg
tricuspid
endocard
contigu
extens
infect
pleural
mediastin
space
recognit
normal
flora
exist
alveolar
level
lung
rather
distal
lung
steril
rais
altern
mechan
develop
bacteri
pneumonia
normal
lung
microbiom
similar
normal
oropharynx
predominantli
streptococci
includ
pneumococcu
also
includ
haemophilu
mycoplasma
cap
pathogen
significantli
lower
concentr
cap
may
therefor
result
perturb
normal
balanc
exampl
viral
uri
result
disrupt
balanc
outgrowth
specif
speci
hypothesi
consist
frequent
associ
anteced
concomit
viral
infect
bacteri
cap
pneumonia
occur
lung
host
defens
must
overcom
normal
lung
host
defens
formid
given
lung
repres
greatest
amount
surfac
area
contact
extern
environ
therefor
routin
expos
infecti
microorgan
result
lung
entir
respiratori
tract
effect
redund
host
defens
mechan
order
respond
infecti
challeng
mechan
factor
critic
import
inhal
pathogen
hair
turbin
nare
branch
architectur
tracheobronchi
tree
trap
microb
airway
line
mucociliari
clearanc
local
antibacteri
factor
either
clear
kill
potenti
pathogen
gag
reflex
cough
play
major
role
protect
aspir
challeng
adher
mucos
cell
oropharynx
normal
flora
prevent
attach
pathogen
bacteria
therebi
decreas
risk
aspir
virul
bacteria
disrupt
normal
microbiom
oropharynx
lung
antibiot
virus
factor
lead
increas
risk
pneumonia
also
predispos
antibioticresist
pathogen
mechan
barrier
overcom
microorgan
small
enough
directli
inhal
alveolar
level
resid
alveolar
macrophag
extrem
effici
clear
kill
pathogen
macrophag
assist
alveolar
epitheli
cell
produc
protein
eg
surfact
protein
opson
properti
direct
antibacteri
antivir
activ
engulf
macrophag
pathogen
even
kill
elimin
via
either
mucociliari
elev
lymphat
capac
alveolar
macrophag
ingest
kill
microorgan
exceed
clinic
pneumonia
becom
manifest
situat
alveolar
macrophag
initi
inflammatori
respons
bolster
lower
respiratori
tract
defens
local
infect
alveolar
space
import
underappreci
compon
host
immun
factor
prevent
bacteremia
defend
vascular
space
poorli
understood
even
presenc
bacteri
dna
peripher
blood
appear
correl
mortal
organ
dysfunct
clearli
preform
antibodi
import
sinc
incontrovert
evid
pneumococc
vaccin
efficaci
prevent
invas
diseas
includ
bacteremia
abil
opson
bacteria
also
import
sinc
defici
mannosebind
lectin
complement
also
chapter
communityacquir
pneumonia
epidemiolog
cap
occur
everi
ecolog
nich
world
arctic
region
desert
jungl
although
frequent
pathogen
may
vari
tabl
list
geograph
zoonot
consider
etiolog
gener
season
pattern
occur
higher
rate
winter
raini
season
track
close
respiratori
virus
influenza
rsv
cap
occur
age
incid
mortal
greatest
extrem
age
infant
lack
humor
immun
common
pathogen
influenza
rsv
streptococcu
pneumonia
major
factor
elderli
senesc
host
immun
system
high
frequenc
comorbid
ill
play
greatest
role
femal
slightli
like
develop
cap
male
like
die
cap
usa
cap
patient
treat
outpati
hospit
patient
requir
icu
monitor
intervent
major
etiolog
cap
list
tabl
far
common
bacteri
etiolog
strep
pneumonia
actual
proport
caus
virus
difficult
determin
sinc
major
detect
upper
respiratori
tract
unclear
whether
viru
present
oropharynx
caus
pneumonia
predispos
superinfect
bacteri
pneumonia
simpli
innoc
bystand
dilemma
obviou
human
rhinoviru
detect
adult
associ
increas
bacteremia
invas
pneumococc
diseas
splenic
clearanc
opson
bacteria
also
import
pneumococcu
encapsul
bacteria
host
inflammatori
respons
rather
simpli
prolifer
microorgan
trigger
clinic
syndrom
pneumonia
releas
inflammatori
mediat
interleukin
il
tumor
necrosi
factor
tnf
result
fever
chemokin
granulocyt
colonystimul
factor
stimul
bone
marrow
releas
neutrophil
home
lung
produc
peripher
leukocytosi
increas
purul
secret
erythrocyt
cross
alveolarcapillari
membran
stage
red
hepat
result
hemoptysi
inflammatori
mediat
releas
macrophag
newli
recruit
neutrophil
caus
alveolar
capillari
leak
equival
demonstr
ard
although
initi
local
pneumonia
radiograph
infiltr
rale
detect
auscult
direct
result
alveolarcapillari
leak
syndrom
hypoxemia
result
alveolar
fill
may
exacerb
paralysi
hypoxem
vasoconstrict
would
normal
occur
fluidfil
alveoli
bacteri
pathogen
increas
respiratori
drive
part
system
inflammatori
respons
syndrom
lead
respiratori
alkalosi
decreas
complianc
due
capillari
leak
hypoxemia
increas
respiratori
drive
increas
secret
occasion
infectionrel
bronchospasm
lead
dyspnea
sever
enough
respiratori
failur
peopl
recogniz
defect
compon
host
defens
develop
cap
howev
sever
manifest
less
virul
pathogen
like
compon
host
defens
defici
genet
defici
everi
compon
host
defens
describ
list
primari
immunodefici
syndrom
increas
yearli
extrins
factor
cigarett
smoke
alcohol
intox
particul
matter
inhal
contribut
howev
import
risk
age
comorbid
ill
diabet
mellitu
chf
emphysema
cirrhosi
liver
failur
even
case
overt
immunocompromis
neutropenia
chemotherapi
leukemia
hiv
diseas
usual
cap
pathogen
still
import
although
differenti
etiolog
becom
much
larger
seri
patholog
chang
seen
classic
lobar
bacteri
pneumonia
describ
tabl
gray
hepat
phase
correspond
success
contain
infect
improv
ga
exchang
restor
normal
hypox
vasoconstrictor
respons
classic
pattern
appli
pneumonia
etiolog
especi
viral
pneumocysti
pneumonia
microaspir
underli
mechan
bronchopneumonia
pattern
seen
correspond
phase
may
occur
set
nurs
home
chronic
dialysi
unit
episod
aspir
week
prior
present
without
interven
medic
attent
classic
predisposit
anaerob
pneumonia
often
complic
empyema
well
otherwis
anaerob
play
minor
role
usual
cap
hcap
propos
discret
entiti
goal
identifi
patient
like
receiv
initi
inappropri
antibiot
therapi
associ
higher
mortal
risk
earli
observ
studi
cultureposit
case
suggest
improv
outcom
broadspectrum
antibiot
therapi
person
hcap
risk
factor
prospect
studi
use
definit
find
lower
rate
antibioticresist
pathogen
mani
cultureneg
case
even
concern
report
advers
outcom
among
person
hcap
risk
factor
treat
broadspectrum
antibiot
therapi
rather
use
origin
definit
deriv
healthcareassoci
bacteremia
prospect
multicent
studi
identifi
six
independ
risk
factor
tabl
pneumonia
caus
pathogen
resist
usual
inpati
antibiot
regimen
recommend
infecti
diseas
societi
america
idsa
american
thorac
societi
at
guidelin
risk
factor
similar
origin
incid
drugresist
pathogen
significantli
increas
three
risk
factor
present
separ
analysi
specif
mrsa
found
presenc
one
mrsaspecif
risk
factor
prior
mrsa
infectioncolon
chronic
hemodialysi
heart
failur
anoth
pneumoniaspecif
risk
factor
may
warrant
mrsa
coverag
dual
antipseudomon
antibiot
importantli
new
definit
would
result
significantli
fewer
patient
receiv
broadspectrum
antibiot
origin
hcap
definit
mrsa
identifi
patient
hcap
risk
factor
like
hospitalacquir
strain
howev
usa
specif
strain
mrsa
caus
cap
previous
healthi
patient
specif
without
hcap
risk
factor
mdr
pathogen
mani
characterist
present
featur
mrsa
strain
tabl
well
methicillinsensit
variant
result
exotoxin
product
pantonvalentin
leukocidin
pvl
gene
effici
marker
toxigen
strain
main
exotoxin
involv
increas
lethal
strain
increasingli
found
hospitalacquir
mrsa
infect
blur
epidemiolog
distinct
diagnosi
cap
rel
straightforward
determin
etiolog
difficult
even
aggress
use
current
avail
diagnost
test
etiolog
remain
unknown
case
complet
histori
travel
pet
hobbi
critic
suspicion
less
common
pathogen
see
tabl
well
cap
less
common
etiolog
usual
associ
specif
geograph
area
exposur
specif
zoonos
see
tabl
occasion
chronic
pulmonari
infect
masquerad
acut
cap
tabl
consid
endem
area
time
cours
indol
concern
rais
communityonset
pneumonia
caus
pathogen
usual
associ
hospitalacquir
pneumonia
even
ventilatorassoci
pneumonia
includ
methicillinresist
staphylococcu
aureu
mrsa
multidrug
resist
mdr
gramneg
pathogen
sever
communityonset
pneumonia
syndrom
risk
drugresist
pathogen
defin
tabl
usa
transfer
hospit
patient
longterm
ventilatorwean
facil
acut
rehabilit
institut
rather
complet
recoveri
acut
care
hospit
decreas
risk
typic
hospitalacquir
pathogen
patient
previous
lump
togeth
lowerrisk
famili
member
mdr
pathogen
gastric
acid
suppress
agent
immunosuppress
diseasetherapi
includ
origin
criteria
frequent
includ
mani
hcap
studi
sinc
outpati
treatment
failur
rare
guidelinecompli
therapi
cover
etiolog
hospit
patient
deviat
guidelin
appropri
justif
presenc
risk
factor
mdr
see
tabl
zoonot
geographicspecif
pathogen
see
tabl
may
justifi
altern
empir
coverag
accompani
aggress
attempt
diagnosi
order
appropri
deescal
broaderspectrum
antibiot
therapi
qualiti
improv
project
consist
show
complianc
idsaat
guidelin
antibiot
increas
mortal
rate
length
stay
decreas
convers
continu
broadspectrum
antibiot
cap
patient
without
document
mdr
pathogen
associ
excess
mortal
macrolid
appear
benefici
effect
excess
coverag
atyp
pathogen
especi
sever
ill
patient
benefit
may
due
immunomodulatori
effect
host
less
cell
lysisinduc
cytokin
releas
inhibit
bacteri
virul
factor
biofilm
quorum
sens
toxin
product
camrsa
would
requir
specif
coverag
sinc
regimen
tabl
inadequ
mrsa
coverag
patient
hcapmrsa
risk
factor
linezolid
better
clinic
respons
rate
vancomycin
manifest
strain
camrsa
cap
disproportion
exotoxinmedi
see
tabl
treatment
antibiot
suppress
toxin
product
linezolid
clindamycin
ad
vancomycin
prefer
associ
lower
mortal
ceftarolin
antibiot
approv
cap
recent
mrsa
activ
well
one
critic
element
treatment
earli
initi
appropri
antibiot
therapi
diagnosi
cap
made
first
dose
given
emerg
depart
ed
allow
closer
monitor
initi
respons
assur
initi
dose
given
promptli
time
first
dose
even
import
patient
present
septic
shock
goal
initi
antibiot
within
first
hour
uncompl
bacteri
cap
usual
durat
treatment
day
certain
pathogen
legionella
may
requir
week
therapi
convers
equival
oral
agent
appropri
whenev
patient
clinic
improv
abl
toler
food
treatment
influenza
pneumonia
prospect
studi
specif
experi
pandem
retrospect
analysi
suggest
antivir
use
patient
mimic
see
tabl
unfortun
diagnosi
mani
pathogen
requir
acut
convalesc
serolog
test
sent
refer
laboratori
make
treatment
empir
gener
greater
likelihood
unusu
bacteri
pathogen
greater
yield
diagnost
test
patient
sever
cap
requir
icu
admiss
andor
hcap
risk
factor
start
broadspectrum
antibiot
clearest
indic
extens
diagnost
test
includ
attempt
obtain
sputum
cultur
yield
test
higher
critic
ill
cap
patient
possibl
endotrach
intub
allow
direct
sampl
lower
respiratori
tract
indic
correspond
appropri
test
list
tabl
biomark
use
attempt
differenti
viral
bacteri
pneumonia
best
valid
procalcitonin
pct
prohormon
elev
uncontrol
bacteri
infect
activ
suppress
interferon
respons
induc
mani
viral
pneumonia
howev
pct
may
low
atyp
pathogen
cap
well
clearli
elev
sever
viral
cap
seen
influenza
pandem
without
evid
superimpos
bacteri
pneumonia
creactiv
protein
crp
nonspecif
pct
cap
may
better
predictor
treatment
failur
treatment
almost
everi
antibiot
approv
us
food
drug
administr
past
four
decad
indic
cap
gener
key
appropri
therapi
adequ
coverag
strep
pneumonia
atyp
bacteri
pathogen
mycoplasma
chlamydophila
legionella
recommend
regimen
idsaat
guidelin
list
tabl
european
guidelin
differ
antibiot
typic
amoxicillin
remain
recommend
agent
mildmoder
cap
recent
studi
netherland
suggest
strategi
empir
treatment
moder
sever
cap
monotherapi
noninferior
either
combin
therapi
fluoroquinolon
monotherapi
primari
factor
discrimin
among
antibiot
option
therefor
local
resist
pattern
commun
organ
recent
antibiot
use
increas
risk
class
resist
new
pleural
effus
patient
admit
cap
alway
prompt
concern
empyema
complic
parapneumon
effus
gener
pleural
fluid
ph
earli
diagnosi
thoracentesi
placement
chest
tube
use
tissu
plasminogen
activ
combin
dnaas
prevent
need
surgic
intervent
major
case
manag
pleural
effus
patient
chf
intermitt
pleural
effus
less
straightforward
thoracentesi
unclear
situat
warrant
patient
benefit
aerosol
bronchodil
wheez
bronchial
hygien
maneuv
difficult
expector
patient
viral
lower
respiratori
tract
infect
occasion
requir
anticholinerg
aerosol
control
nonproduct
cough
use
system
corticosteroid
cap
patient
indic
eg
asthma
copd
exacerb
associ
pneumonia
remain
controversi
moder
diseas
potenti
benefit
shorten
hospit
counterbalanc
increas
risk
superinfect
sever
viral
pneumonia
either
sar
influenza
pandem
steroid
use
associ
wors
outcom
mention
cap
exacerb
underli
chronic
ill
asthma
copd
diabet
mellitu
chf
patient
admit
pneumococc
cap
new
cardiovascular
diagnosi
acut
hospit
includ
acut
myocardi
infarct
atrial
fibril
arrhythmia
chf
destabil
comorbid
ill
like
caus
hospit
readmiss
complic
cap
treatment
main
cap
prevent
measur
vaccin
smoke
cessat
even
among
patient
without
obstruct
lung
diseas
smoker
increas
risk
pneumococc
cap
two
form
influenza
vaccin
avail
intramuscular
inactiv
influenza
vaccin
intranas
liveattenu
coldadapt
influenza
vaccin
latter
contraind
immunocompromis
patient
specif
vaccin
compon
reassess
yearli
base
main
circul
strain
opposit
hemispher
event
influenza
outbreak
unprotect
patient
risk
complic
vaccin
immedi
given
chemoprophylaxi
oseltamivir
week
time
vaccineinduc
antibodi
level
suffici
protect
pneumococc
polysaccharid
vaccin
protein
conjug
vaccin
avail
usa
vaccin
efficaci
question
particularli
elderli
atrisk
popul
administr
protein
conjug
vaccin
children
led
overal
decreas
preval
antimicrobialresist
pneumococci
incid
invas
pneumococc
diseas
among
children
adult
howev
vaccin
may
result
replac
vaccin
serotyp
nonvaccin
serotyp
seen
serotyp
introduct
origin
conjug
vaccin
conjug
vaccin
also
recommend
elderli
younger
immunocompromis
patient
see
also
chapter
refer
avail
onlin
expertconsultcom
radiograph
infiltr
matter
durat
symptom
potenti
oseltamivirresist
strain
monitor
cdc
local
health
depart
inform
influenza
season
progress
major
issu
whether
antibiot
alway
need
influenza
cap
clear
data
consensu
full
descript
use
antivir
therapi
see
chapter
major
determin
cost
cap
care
physician
decis
hospit
cap
patient
present
ed
admit
consider
variabl
admiss
patient
similar
clinic
characterist
use
score
system
pneumonia
sever
index
psi
score
develop
specif
guid
admiss
decis
result
fewer
admiss
low
acuiti
patient
increas
advers
outcom
psi
complex
score
requir
formal
score
electron
decis
support
wherea
confus
uremia
respiratori
rate
blood
pressur
age
year
easi
rememb
calcul
although
well
valid
psi
score
valid
analysi
group
cap
admiss
admiss
low
score
patient
legitim
object
reason
eg
low
arteri
satur
subject
eg
unreli
home
support
concern
regard
complianc
decis
regard
initi
icu
placement
tenuou
cap
patient
probabl
greatest
potenti
impact
mortal
patient
transfer
icu
within
hour
initi
admiss
gener
medic
servic
higher
mortal
obviou
need
icu
care
mechan
ventil
hypotens
requir
vasopressor
time
admiss
fraction
hospit
pneumonia
patient
admit
icu
also
vari
wide
depend
hospit
health
system
characterist
idsaat
guidelin
suggest
presenc
group
nine
minor
criteria
tabl
warrant
consider
icu
admiss
score
predict
clinic
deterior
similar
paramet
also
develop
valid
probabl
need
invas
ventilatori
vasopressor
therapi
increas
increas
number
criteria
point
threshold
score
around
three
consid
icu
admiss
icu
admiss
score
overli
sensit
result
substanti
icu
admiss
follow
rigidli
appropri
use
score
may
focu
attent
patient
high
score
still
ed
qualityimprov
studi
demonstr
increas
attent
ed
patient
idsaat
minor
criteria
idsaat
criteria
criteria
minor
criteria
consider
icu
admiss
sever
cap
